RecruitingPhase 3NCT06617325A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusSponsor: UCB Biopharma SRLChicago, IL · Willowbrook, IL · +61 more sites
RecruitingPhase 3NCT06133972Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).Sponsor: Novartis PharmaceuticalsSkokie, IL · Willowbrook, IL · +23 more sites
RecruitingPhase 3NCT07430306A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusSponsor: AstraZenecaWillowbrook, IL · +30 more sites
RecruitingPhase 3NCT07438496A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusSponsor: Janssen Research & Development, LLCWillowbrook, IL · +37 more sites
RecruitingPhase not listedNCT07175285A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 ImmunosuppressantsSponsor: Bristol-Myers SquibbWillowbrook, IL · +25 more sites